Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance

Conclusion: 18F-Fluciclovine PET/CT significantly altered salvage radiotherapy decisions in patients with recurrent PCa after prostatectomy. Further analysis to determine the impact of 18F-fluciclovine PET/CT guidance on clinical outcomes after radiotherapy is in progress.

Source: Journal of Nuclear Medicine - July 30, 2021 Category: Nuclear Medicine Authors: Abiodun-Ojo, O. A., Jani, A. B., Akintayo, A. A., Akin-Akintayo, O. O., Odewole, O. A., Tade, F. I., Joshi, S. S., Master, V. A., Fielder, B., Halkar, R. K., Zhang, C., Goyal, S., Goodman, M. M., Schuster, D. M. Tags: Clinical Investigations Source Type: research